During the COVID-19 pandemic, our members are developing research to address COVID-19 related challenges. New projects are described in summary here. Further details will be published as soon as possible. Meanwhile our staff have taken on extended clinical roles. See this post for details. New COVID-19-related research at the Unit 1. Using linked primary care […]
Which cancer diagnostic tests will work best in primary care? New CanTest Framework published today will help provide answers
The CanTest Framework, which provides a conceptual approach for the evaluation of cancer diagnostic tests from development to routine use in primary care, has been published today in BMC Cancer. Developed by the CanTest Senior Faculty team, this new framework addresses some key aspects missing from previous approaches. It incorporates a shift in focus away […]
Pushing forward on primary care cancer diagnosis: the CanTest Collaborative two years on
Blog by Dr Valerie Sills, Programme Manager for the CRUK-funded CanTest Programme. The CanTest programme supports research, capacity building and collaboration in the field of early detection and diagnosis of cancer in primary care. CanTest was announced by Cancer Research UK as the winner of the first ever Catalyst Award in January 2017, so the […]
Further research needed to identify possible warning signs of brain tumours, say experts
Experts at the University of Cambridge have called for more research that might improve the early detection of brain tumours, following a qualitative study that suggests there are subtle changes in the patient’s functioning and wellbeing that might act as tell-tale signs of the onset of disease. The researchers caution that this research will also […]
Lung cancer survivors could benefit from check-ups for new cancers for at least ten years
Five-year survival of patients with lung cancer has doubled in England during the past 15 years as lung cancer treatment has become more effective, leading to increasing numbers of survivors. So, optimising surveillance of second primary cancer in this high risk group is becoming increasingly important. Understanding how often such second cancers develop and when […]
A simple questionnaire could be a cost-effective way to monitor for melanoma skin cancer
Melanoma is rare, but also the most dangerous form of skin cancer, with around 14,500 new cases diagnosed and 2600 deaths in the UK each year. Early detection is critical: overall, around 90 in every 100 patients with melanoma will still be alive five years after diagnosis. But for those diagnosed with advanced disease, only […]